胆固醇投射神经元的突触放松调节导致五种飞行帕金森症模型中的嗅觉功能障碍
Ulrike Pech1,2, Jasper Janssens1,3,4, Nils Schoovaerts1,2
1VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.
eLife
|April 3, 2025
概括
早期的帕金森症涉及胆固醇神经元的突触功能障碍,导致运动症状出现多年前的嗅觉丧失 (低敏症). 这项研究确定了果模型和人类细胞中的关键细胞缺陷,提供了新的诊断和治疗点.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 细胞生物学 细胞生物学
背景情况:
- 帕金森症的诊断依赖于多巴胺能神经元损失的运动症状.
- 非运动性症状,如低血,在运动缺陷之前多年,但其原因尚不清楚.
- 了解早期的细胞变化对于及时介入帕金森病至关重要.
研究的目的:
- 研究家族性帕金森症早期非运动症状的细胞和分子基础.
- 识别易受伤害的细胞类型和受到帕金森病发病早期影响的分子通路.
- 探索针对早期突触功能障碍的潜在治疗策略.
主要方法:
- 为家族帕金森症开发了五种果模型.
- 在年轻果大脑和帕金森病患者的大脑组织上进行单细胞和单核RNA测序.
- 利用在和体外细胞模型中的基因操纵来测试治疗干预措施.
主要成果:
- 在早期帕金森症模型中,胆固醇投射神经元被确定为最脆弱的细胞类型.
- 调节突触前功能的基因被显著放松调节,这表明早期突触功能障碍.
- 胆固醇嗅觉神经元中的突触缺陷与模型中的低相关.
- 纠正胆固醇神经元中的突触功能障碍或增强胆固醇信号传递改善了多巴胺激素神经元衰退.
结论:
- 高级胆固醇投射神经元中的突触功能障碍是家族帕金森症的早期指标,有助于低.
- 在胆固醇神经元中,共享的突触失效路径先于并导致后期的多巴胺功能障碍.
- 准胆固醇信号通路可能为早期帕金森症干预提供治疗方法.
关键词:
D. melanogaster. D. melanogaster. D. melanogaster. D. melanogaster. D. melanogaster. D. melanogaster. D. melanogaster. D. melanogaster. D. melanogaster. D. melanogaster. D. melanogaster. D. melanogaster. D. melanogaster. D. melanogaster. D. melanogaster. D. melanogaster. melanogaster. D. melanogaster. melanogaster. D. melanogaster. D. melanogaster. melanogaster. D.帕金森病是帕金森病的一种.胆固醇神经元是一种神经元.多巴胺类神经元的神经元人类 人类 人类 人类 人类 人类 人类神经科学 神经科学嗅觉 嗅觉是一种嗅觉.一个单细胞RNA测序.相关概念视频
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Excitatory and Inhibitory Effects of Neurotransmitters
9.6K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
9.6K
Parkinson's Disease: Overview
360
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
360
Parkinson's Disease: Treatment
163
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
163


